Tag: Diagnostic biomarker Market

Companion Diagnostics Market
Healthcare

Companion Diagnostics: Impact of the COVID-19 Pandemic in Diagnostic Biomarker Market

Advantages of companion diagnostics, the growing need for targeted therapy, the rising importance of personalized medicine, the increasing global incidence of cancer, and the ever-increasing application areas of companion diagnostics are driving the growth of the global companion diagnostics industry. [333 Pages Report] The companion diagnostics market is expected to reach USD 6.8 billion by 2025 from USD 3.7 billion in 2020, at a CAGR of 12.9% … Continue reading Companion Diagnostics: Impact of the COVID-19 Pandemic in Diagnostic Biomarker Market

Ritika Tyagi
Pharmaceuticals

North American nuclear medicine market : Initiatives to Lessen the Demand-Supply Gap of Mo-99

Growth in the market can primarily be attributed to factors such as the increasing incidence and prevalence of cancer & cardiac ailments and initiatives to lessen the demand-supply gap of Mo-99. However, the short half-life of radiopharmaceuticals reduces their potential adoption, while hospital budget cuts and high equipment prices are expected to limit market growth to a certain extent. The North American nuclear medicine market is expected … Continue reading North American nuclear medicine market : Initiatives to Lessen the Demand-Supply Gap of Mo-99

sasha sharma
Companion Diagnostics Market
Biotechnology, Healthcare, Medical Devices, Pharmaceuticals, Technology

COVID-19: Companion Diagnostics Market Growth in Healthcare at a CAGR of 12.9%

Advantages of companion diagnostics, the growing need for targeted therapy, the rising importance of personalized medicine, the increasing global incidence of cancer, and the ever-increasing application areas of companion diagnostics are driving the growth of the global companion diagnostics industry. The increasing demand for next-generation sequencing, the growing significance of companion diagnostics in drug development, and the rising number of clinical trials are the major … Continue reading COVID-19: Companion Diagnostics Market Growth in Healthcare at a CAGR of 12.9%

Ritika Tyagi
Companion Diagnostics Market
Biotechnology, Healthcare, Pharmaceuticals, Technology

Companion Diagnostics Market: Pharmaceutical and Biopharmaceutical Industries Shows Promising Future

The growth of the companion diagnostics market is tied primarily to the advantages of companion diagnostics, the growing need for targeted therapy, the increasing importance of personalized medicine, the rising global incidence of cancer, and the ever-increasing application areas of companion diagnostics. What the Market Looks Like? Predicted to grow at a CAGR of 15.7% during the forecast period, the global Companion Diagnostics Market is estimated to … Continue reading Companion Diagnostics Market: Pharmaceutical and Biopharmaceutical Industries Shows Promising Future

Ritika Tyagi
Companion Diagnostics Market
Biotechnology, Healthcare, Pharmaceuticals

Global Companion Diagnostics Market Top Players, Business Opportunities, Latest Industry Trends And Applications

A companion diagnostic assay is an in vitro diagnostic device (IVD) that is used to identify whether a patient with certain diseases could be benefitted by a particular drug through the biomarker assessment. The key factors driving the growth of this market include the increasing lung cancer cases, growing number of genetic testing, rising need for personalized medicines, and regulatory guidelines that support the companion diagnostics … Continue reading Global Companion Diagnostics Market Top Players, Business Opportunities, Latest Industry Trends And Applications

Ritika Tyagi